Drug Metabolism Letters
Volume 15, 3 Issues, 2021
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
ISSN: 1874-0758 (Online)
ISSN: 1872-3128 (Print)
This journal supports open access
In the current pandemic scenario, publication process of all articles related to Coronavirus will be expedited, for timely publication of much needed research
Contents
Drug Metabolism Letters, Volume 10 - Number 2
Commentary: A Myriad Aberrations on Information of Ontogeny of Drug Metabolizing Enzymes in the Pediatric Population: An Obstacle for Personalizing Drug Therapy in the Pediatric Population
, 10(2): 72 - 74Chakradhara Rao S. Uppugunduri and Marc Ansari
DOI: 10.2174/1872312810666160224143443
The Effects of Statin Therapy on the Human Airway
, 10(2): 75 - 82Lorraine Thong, John MacSharry and Desmond M. Murphy
DOI: 10.2174/1872312810666160303112012
The Effects of Statin Therapy on the Human Airway
Efficiency in Drug Discovery: Liver S9 Fraction Assay As a Screen for Metabolic Stability
, 10(2): 83 - 90Samantha J. Richardson, April Bai, Ashutosh A. Kulkarni and Mehran F. Moghaddam
DOI: 10.2174/1872312810666160223121836
Efficiency in Drug Discovery: Liver S9 Fraction Assay As a Screen for Metabolic Stability
Rate-Determining and Rate-Limiting Steps in the Clearance and Excretion of a Potent and Selective p21-Activated Kinase Inhibitor: A Case Study of Rapid Hepatic Uptake and Slow Elimination in Rat
, 10(2): 91 - 100Peter W. Fan, Jacob Z. Chen, M. Allan Jaochico, Hank La, Ning Liu, Teresa Mulder, Robert T. Cass, Matthew Durk, Kirsten Messick, Nicole Valle, Shannon Liu, Wendy Lee, James J. Crawford, Joachim Rudolf, Lesley J. Murray, S. Cyrus Khojasteh and Matthew Wright
DOI: 10.2174/1872312810666160411144358
Rate-Determining and Rate-Limiting Steps in the Clearance and Excretion of a Potent and Selective p21-Activated Kinase Inhibitor: A Case Study of Rapid Hepatic Uptake and Slow Elimination in Rat
In Vitro Study of UGT Metabolism and Permeability of Orientin and Isoorientin, Two Active flavonoid C-glycosides
, 10(2): 101 - 110Jian Shi, Lijun Zhu, Ye Li, Haihui Zheng, Jia Yu, Linlin Lu and Zhongqiu Liu
DOI: 10.2174/1872312810666160219121217
In Vitro Study of UGT Metabolism and Permeability of Orientin and Isoorientin, Two Active flavonoid C-glycosides
Biotransformation of Cobicistat: Metabolic Pathways and Enzymes
, 10(2): 111 - 123Pengcheng Wang, Amina I. Shehu, Ke Liu, Jie Lu and Xiaochao Ma
DOI: 10.2174/1872312810666160303112212
Biotransformation of Cobicistat: Metabolic Pathways and Enzymes
In Vitro CYP2D Inhibitory Effect and Influence on Pharmacokinetics and Pharmacodynamic Parameters of Metoprolol Succinate by Terminalia arjuna in Rats
, 10(2): 124 - 135Alice Varghese, Jay Savai, Shruti Mistry, Preeti Khandare, Kalyani Barve, Nancy Pandita and Ram Gaud
DOI: 10.2174/1872312810666160219121415
In Vitro CYP2D Inhibitory Effect and Influence on Pharmacokinetics and Pharmacodynamic Parameters of Metoprolol Succinate by Terminalia arjuna in Rats
Elucidating the Mechanism of Tofacitinib Oxidative Decyanation
, 10(2): 136 - 143Hoa Le, Peter W. Fan, Susan Wong, Shuguang Ma, James P. Driscoll, Cornelis E.C.A. Hop and S. Cyrus Khojasteh
DOI: 10.2174/1872312810666160427104954
Elucidating the Mechanism of Tofacitinib Oxidative Decyanation
Formation of A Novel Purine Metabolite through CYP3A4 Bioactivation and Glutathione Conjugation
, 10(2): 144 - 150Julius L. Apuy, Cathie Xiang, Sarah Franc, Sayee G. Hegde, Robert Hubbard, Jingjing Zhao and Mehran F. Moghaddam
DOI: 10.2174/1872312810666160511150558
Formation of A Novel Purine Metabolite through CYP3A4 Bioactivation and Glutathione Conjugation
Editor-in-Chief
Zhiyang Zhao
Alliance Pharma
Malvern, PA
(USA)
Biography
Alliance Pharma
Malvern, PA
Biography
Biography of Zhiyang Zhao
Zhiyang Zhao received his Ph.D. degree in Medicinal Chemistry from Virginia Tech, Blacksburg, Virginia, USA. Dr. Zhao’s biopharmaceutical/pharmaceutical work experience encompasses over 25 years of research in metabolic and pharmacokinetic properties of compounds for drug discovery and development at Pfizer, GlaxoSmithKline and Amgen. Currently, Dr. Zhao serve as Chief Scientific Officer (CSO) at Alliance Pharma, Inc. and appointed as an adjunct professor at the School of Pharmacy, the University of North Carolina at Chapel Hill. Dr. Zhao has published over 50 peer reviewed original research papers and patents in the areas of new drug targets, drug metabolism, pharmacokinetics, and toxicology.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Drug Metabolism Letters was launched in 2007. Dr. Zhiyang Zhao serves as the Editor-in-Chief of the journal.
Scopus CiteScore Metrics: 1.01
Advertisement
Webmaster Contact: info@benthamscience.net